1. Home
  2. NVCR vs VEON Comparison

NVCR vs VEON Comparison

Compare NVCR & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • VEON
  • Stock Information
  • Founded
  • NVCR 2000
  • VEON 1992
  • Country
  • NVCR Jersey
  • VEON Netherlands
  • Employees
  • NVCR N/A
  • VEON N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • VEON Telecommunications Equipment
  • Sector
  • NVCR Health Care
  • VEON Telecommunications
  • Exchange
  • NVCR Nasdaq
  • VEON Nasdaq
  • Market Cap
  • NVCR 1.8B
  • VEON 2.1B
  • IPO Year
  • NVCR 2015
  • VEON 1996
  • Fundamental
  • Price
  • NVCR $17.49
  • VEON $30.33
  • Analyst Decision
  • NVCR Buy
  • VEON
  • Analyst Count
  • NVCR 5
  • VEON 0
  • Target Price
  • NVCR $26.60
  • VEON N/A
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • VEON 29.2K
  • Earning Date
  • NVCR 10-30-2024
  • VEON 11-14-2024
  • Dividend Yield
  • NVCR N/A
  • VEON N/A
  • EPS Growth
  • NVCR N/A
  • VEON N/A
  • EPS
  • NVCR N/A
  • VEON N/A
  • Revenue
  • NVCR $549,964,000.00
  • VEON $3,867,000,000.00
  • Revenue This Year
  • NVCR $16.23
  • VEON $11.98
  • Revenue Next Year
  • NVCR $6.09
  • VEON $7.27
  • P/E Ratio
  • NVCR N/A
  • VEON $7.05
  • Revenue Growth
  • NVCR 8.33
  • VEON 6.53
  • 52 Week Low
  • NVCR $10.87
  • VEON $15.10
  • 52 Week High
  • NVCR $24.74
  • VEON $32.69
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • VEON 53.19
  • Support Level
  • NVCR $15.61
  • VEON $30.10
  • Resistance Level
  • NVCR $17.31
  • VEON $32.00
  • Average True Range (ATR)
  • NVCR 1.29
  • VEON 0.99
  • MACD
  • NVCR 0.05
  • VEON -0.04
  • Stochastic Oscillator
  • NVCR 11.59
  • VEON 50.37

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About VEON VEON Ltd. ADS

VEON Ltd is a global provider of connectivity and internet services. The company provides its customers with voice, fixed broadband, data, and digital services. Currently, the company offers services to customers in the following countries: Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. The reportable segments currently consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. The company provides services under the Beeline, Kyivstar, banglalink and Jazz brands.

Share on Social Networks: